Clinical trial

Proton Beam Radiation Therapy After Treatment for Resected N2 Non-Small Cell Lung Cancer

NCT06008730

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

PROCEDURE · Unmapped registry intervention Biospecimen Collection Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention Proton Beam Radiation Therapy Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Radiology, Treatment Planning Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Proton Beam Radiation Therapy After Treatment for Resected N2 Non-Small Cell Lung Cancer

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-12-13

PhasePHASE2

Conditions

Resectable Lung Non-Small Cell Carcinomaunresolved

Interventions

Biospecimen CollectionPROCEDURE

Proton Beam Radiation TherapyRADIATION

Radiology, Treatment PlanningOTHER

Sponsors & collaborators

Emory Universitylead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

AtlantaGeorgia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06008730 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.